
A randomized controlled trial comparing guided internet-based multi-component 
treatment and internet-based guided sleep restriction treatment to care as usual in 
insomnia 
Tobias Krieger, Antoine Urech, Simone B. Duss, Larissa Blättler, Wolfgang Schmitt, 
Heidemarie Gast, Claudio Bassetti, Thomas Berger 











Please cite this article as: Krieger T, Urech A, Duss SB, Blättler L, Schmitt W, Gast H, Bassetti C, 
Berger T, A randomized controlled trial comparing guided internet-based multi-component treatment and 
internet-based guided sleep restriction treatment to care as usual in insomnia, Sleep Medicine, https:// 
doi.org/10.1016/j.sleep.2019.01.045. 
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to 
our customers we are providing this early version of the manuscript. The manuscript will undergo 
copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please 
note that during the production process errors may be discovered which could affect the content, and all 
legal disclaimers that apply to the journal pertain. 

 
 




















21 
22 
















Tobias Krieger1±*, Antoine Urech1,2±, Simone B. Duss3, Larissa Blättler1, Wolfgang Schmitt3, 
Heidemarie Gast3, Claudio Bassetti3+, Thomas Berger1+ 
1 Institute for Psychology, University of Bern, Bern, Switzerland 
2 Neurorehabilitation Dept. of Neurology, Hospital, and University of Bern, Riggisberg, 
Switzerland 
3 Sleep-Wake-Epilepsy-Center, Department of Neurology, Inselspital, Bern University 

± These authors share first authorship 
+ These authors share senior authorship 

















 
 
 
 
 
 
 
 
 
 
 
 
 
 

 













 
 
 



































































 
 
 
 
 









































































 
 











































































 
 







































































 
 







































































 
 



















Center for Epidemiological Studies Depression Scale (CES-D) (Radloff, 1977), the 
“Allgemeine Depressions‐Skala – Kurzform” (ADS-K) (Hautzinger and Bailer, 1993). To 




















































 
 









































































 
 







































All statistical analyses were performed with SPSS or R (R Core Team, 2018) and the 
packages nlme (Pinheiro et al., 2018). ANOVAs and ??2-tests were used to detect differences 






























 
 































although they had been invited three times at weekly intervals via email. Non-completion 
rates did not differ with respect to experimental group, ??2(2, n=104) = 2.34, p = .31, V = 




































 
 





























post-treatment. Significantly more cases in the MCT showed response compared to CAU, 
??2(1, n=63) = 6.37, p = .012, V = 0.32. This was not the case for the SRT group compared to 
CAU, ??2(1, n=62) = 3.73, p = .054, V = 0.25. However, the two active conditions did not 
significantly differ between each other ??2(1, n=83) = 0.69, p = .41, V = 0.09. 







in the SRT (n = 10), and 38.1% (n = 16) in the MCT condition were considered remitted at 
post-treatment. Significantly more cases in the MCT remitted compared to the CAU, ??2(1, 
n=63) = 7.90, p = .005, V = 0.35. This was not the case for the SRT group compared to the 
CAU, ??2(1, n=62) = 3.67, p = .056, V = 0.24. Again, the two active groups did not differ 
from each other ??2(1, n=83) = 1.81, p = .178, V = 0.15. 
























 
 





suffering from insomnia than in the control condition, p’s < .028. The two treatments did not 
significantly differ from each other at post-assessment, ??2(1, n=83) = 0.11, p = .74, V = -0.04. 




















































fulfilled the criteria for insomnia at follow-up. This difference, however, was not statistically 
significant, ??2(1, n=83) = 1.49, p = .22, V = 0.13. 








 
 





































































 
 











































































 
 











































































 
 


































































 
 
 
 


































 
 
 
 
 
 

520 
521 
522 
523 
524 
525 
526 
527 
528 
529 
530 
531 
532 
533 
534 
535 
536 
537 
538 
539 
540 
541 
542 
543 
544 
545 
546 
547 
548 
549 
550 
551 
552 
553 
554 
555 
556 
557 
558 
559 
560 
561 
562 
563 
564 
565 
566 
567 
568 
569 
570 
REFERENCES 
ACKENHEIL, M., STOTZ, G., DIETZ-BAUER, R. & VOSSEN, A. 1999. Mini 
International Neuropsychiatric Interview. German version 5.0.0., München, 
Psychiatrische Universitätsklinik München. 
AMERICAN ACADEMY OF SLEEP MEDICINE 2014. International classification of sleep 
disorders–third edition (ICSD-3). Darien, IL: American Academy of Sleep Medicine. 
ANDERSSON, G. & TITOV, N. 2014. Advantages and limitations of internet‐based 
interventions for common mental disorders. World Psychiatry, 13, 4-11. 
ATTKISSON, C. C. & GREENFIELD, T. K. 2004. The UCSF Client Satisfaction Scales: I. 
The Client Satisfaction Questionnaire-8. In: MARUISH, M. E. (ed.) The use of 
psychological testing for treatment planning and outcomes assessment. 3rd ed. 
Mahwah, NJ: Lawrence Erlbaum Associates. 

Severity Index as an outcome measure for insomnia research. Sleep medicine, 2, 297- 
307. 
BLOM, K., JERNELÖV, S., RÜCK, C., LINDEFORS, N. & KALDO, V. 2017. Three-year 
follow-up comparing cognitive behavioral therapy for depression to cognitive 
behavioral therapy for insomnia, for patients with both diagnoses. Sleep, 40. 
BLOM, K., TILLGREN, H. T., WIKLUND, T., DANLYCKE, E., FORSSÉN, M., 
SÖDERSTRÖM, A., JOHANSSON, R., HESSER, H., JERNELÖV, S. & 
LINDEFORS, N. 2015. Internet-vs. group-delivered cognitive behavior therapy for 
insomnia: a randomized controlled non-inferiority trial. Behaviour Research and 
Therapy. 



1989. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice 
and research. Psychiatry research, 28, 193-213. 

TALLENT, G., TRAN, K. M., AHMEDANI, B. K., ROEHRS, T. & ROTH, T. 2018. 
Efficacy of digital CBT for insomnia to reduce depression across demographic groups: 
a randomized trial. Psychological medicine, 1-10. 

A. 2007. Patient expectations and therapeutic alliance as predictors of outcome in 
group cognitive-behavioral therapy for insomnia. Behavioral Sleep Medicine, 5, 210- 
228. 

Insomnia (CBT-I) to treat depression: A systematic review. Journal of Psychosomatic 
Research, 106, 1-12. 
DALEY, M., MORIN, C. M., LEBLANC, M., GRÉGOIRE, J.-P. & SAVARD, J. 2009. The 
economic burden of insomnia: direct and indirect costs for individuals with insomnia 
syndrome, insomnia symptoms, and good sleepers. Sleep, 32, 55-64. 

multicomponent behavioral treatment for insomnia in older adults: a randomized 
controlled trial. Sleep, 35, 797-805. 

TRACHSLER, E., PÜHSE, U. & BRAND, S. 2016. Validation of the German version 
of the insomnia severity index in adolescents, young adults and adult workers: results 
from three cross-sectional studies. BMC Psychiatry, 16, 174. 










 
 

571 
572 
573 
574 
575 
576 
577 
578 
579 
580 
581 
582 
583 
584 
585 
586 
587 
588 
589 
590 
591 
592 
593 
594 
595 
596 
597 
598 
599 
600 
601 
602 
603 
604 
605 
606 
607 
608 
609 
610 
611 
612 
613 
614 
615 
616 
617 
618 
619 
620 
SOEHNER, A. M. 2014. Comparative efficacy of behavior therapy, cognitive therapy, 
and cognitive behavior therapy for chronic insomnia: a randomized controlled trial. 
Journal of consulting and clinical psychology, 82, 670. 

disturbance as transdiagnostic: consideration of neurobiological mechanisms. Clinical 
psychology review, 31, 225-235. 

components and relationship to long-term clinical outcome. Behaviour research and 
therapy, 40, 75-83. 



BONSEL, G. & BADIA, X. 2011. Development and preliminary testing of the new 
five-level version of EQ-5D (EQ-5D-5L). Quality of life research, 20, 1727-1736. 
HO, F. Y.-Y., CHUNG, K.-F., YEUNG, W.-F., NG, T. H.-Y. & CHENG, S. K.-W. 2014. 
Weekly brief phone support in self-help cognitive behavioral therapy for insomnia 
disorder: Relevance to adherence and efficacy. Behaviour research and therapy, 63, 
147-156. 

HOLMQVIST, M., VINCENT, N. & WALSH, K. 2014. Web-vs telehealth-based delivery of 
cognitive behavioral therapy for insomnia: a randomized controlled trial. Sleep 
medicine, 15, 187-195. 

& KALDO, V. 2012. Efficacy of a behavioral self-help treatment with or without 
therapist guidance for co-morbid and primary insomnia-a randomized controlled trial. 
BMC Psychiatry, 12, 5. 

KRAEPELIEN, M., RÜCK, C. & LINDEFORS, N. 2015. Guided internet cognitive 
behavioral therapy for insomnia compared to a control treatment–a randomized trial. 
Behaviour research and therapy, 71, 90-100. 

ESPIE, C. A. & SPIELMAN, A. J. 2015. Towards standardisation and improved 
understanding of sleep restriction therapy for insomnia disorder: a systematic 
examination of CBT-I trial content. Sleep medicine reviews, 23, 83-88. 
KYLE, S. D., MILLER, C. B., ROGERS, Z., SIRIWARDENA, A. N., MACMAHON, K. M. 
& ESPIE, C. A. 2014. Sleep restriction therapy for insomnia is associated with 
reduced objective total sleep time, increased daytime somnolence, and objectively 
impaired vigilance: implications for the clinical management of insomnia disorder. 
Sleep, 37, 229-237. 

gain: an exploratory within-subjects mixed-methods evaluation of the patient 
experience of sleep restriction therapy (SRT) for insomnia. Sleep medicine, 12, 735- 
747. 

Klassifikation der Schlafstörungen: Übersicht über die Änderungen in der ICSD-3. 
Somnologie - Schlafforschung und Schlafmedizin, 19, 116-125. 
MILLER, C. B., ESPIE, C. A., EPSTEIN, D. R., FRIEDMAN, L., MORIN, C. M., PIGEON, 
W. R., SPIELMAN, A. J. & KYLE, S. D. 2014. The evidence base of sleep restriction 
therapy for treating insomnia disorder. Sleep medicine reviews, 18, 415-424. 









 
 

621 
622 
623 
624 
625 
626 
627 
628 
629 
630 
631 
632 
633 
634 
635 
636 
637 
638 
639 
640 
641 
642 
643 
644 
645 
646 
647 
648 
649 
650 
651 
652 
653 
654 
655 
656 
657 
658 
659 
660 
661 
662 
663 
664 
665 
666 
667 
668 
669 
670 
671 
of the recent evidence (1998-2004). SLEEP-NEW YORK THEN WESTCHESTER-, 29, 
1398. 





BASTIEN, C. & BAILLARGEON, L. 2009. Cognitive behavioral therapy, singly and 
combined with medication, for persistent insomnia: a randomized controlled trial. 
Jama, 301, 2005-2015. 






OKAJIMA, I., KOMADA, Y. & INOUE, Y. 2011. A meta‐analysis on the treatment 
effectiveness of cognitive behavioral therapy for primary insomnia. Sleep and 
Biological Rhythms, 9, 24-34. 


PERLIS, M. L., JUNGQUIST, C., SMITH, M. T. & POSNER, D. 2006. Cognitive behavioral 
treatment of insomnia: A session-by-session guide, Springer Science & Business 
Media. 








RIEMANN, D., BAGLIONI, C., BASSETTI, C., BJORVATN, B., DOLENC GROSELJ, L., 
ELLIS, J. G., ESPIE, C. A., GARCIA‐BORREGUERO, D., GJERSTAD, M. & 
GONÇALVES, M. 2017. European guideline for the diagnosis and treatment of 
insomnia. Journal of sleep research, 26, 675-700. 



BAILEY, E. T., SAYLOR, D. K. & MORIN, C. M. 2009. Efficacy of an Internet- 
based behavioral intervention for adults with insomnia. Archives of general 
psychiatry, 66, 692-698. 
SCHMIDT, J., LAMPRECHT, F. & WITTMANN, W. 1989. Zufriedenheit mit der 
stationären Versorgung. Entwicklung eines Fragebogens und erste 
Validitätsuntersuchungen. Psychotherapie, Psychosomatik, Medizinische Psychologie, 
39, 248-255. 

Clinical guideline for the evaluation and management of chronic insomnia in adults. 
Journal of Clinical Sleep Medicine, 4, 487-504. 










 
 

therapy to treat insomnia: a systematic review and meta-analysis. PLoS One, 11, 
e0149139. 


SPIELMAN, A. J., SASKIN, P. & THORPY, M. J. 1987. Treatment of chronic insomnia by 
restriction of time in bed. Sleep: Journal of Sleep Research & Sleep Medicine. 
TRAUER, J. M., QIAN, M. Y., DOYLE, J. S., RAJARATNAM, S. M. & CUNNINGTON, 
D. 2015. Cognitive behavioral therapy for chronic insomnia: a systematic review and 
meta-analysis. Annals of internal medicine, 163, 191-204. 
VAN DER ZWEERDE, T., VAN STRATEN, A., EFFTING, M., KYLE, S. & LANCEE, J. 
2018. Does online insomnia treatment reduce depressive symptoms? A randomized 
controlled trial in individuals with both insomnia and depressive symptoms. 
Psychological medicine, 1-9. 


VAN STRATEN, A., EMMELKAMP, J., DE WIT, J., LANCEE, J., ANDERSSON, G., 
VAN SOMEREN, E. & CUIJPERS, P. 2014. Guided Internet-delivered cognitive 
behavioural treatment for insomnia: a randomized trial. Psychological medicine, 44, 
1521-1532. 




WU, J. Q., APPLEMAN, E. R., SALAZAR, R. D. & ONG, J. C. 2015. Cognitive behavioral 
therapy for insomnia comorbid with psychiatric and medical conditions: a meta- 
analysis. JAMA internal medicine, 175, 1461-1472. 

YANG, X.-J. & JIANG, X.-J. 2016. Internet-based cognitive–behavioural therapy for 
insomnia (ICBT-i): a meta-analysis of randomised controlled trials. BMJ Open, 6, 
e010707. 


ZACHARIAE, R., LYBY, M. S., RITTERBAND, L. M. & O'TOOLE, M. S. 2016. Efficacy 
of internet-delivered cognitive-behavioral therapy for insomnia–a systematic review 
and meta-analysis of randomized controlled trials. Sleep medicine reviews, 30, 1-10. 
672 
673 
674 
675 
676 
677 
678 
679 
680 
681 
682 
683 
684 
685 
686 
687 
688 
689 
690 
691 
692 
693 
694 
695 
696 
697 
698 
699 
700 
701 
702 
703 
704 
705 
706 
707 






 
 

 
 
 







































 
 
 
MCT 
(n = 42) 
42.17 
(12.40) 
SRT 
(n = 41) 
46.59 (17.52) 
CAU 
(n = 21) 
45.24 
(12.40) 



 
 
 
 
Table 2 
Baseline demographics and sample characteristics for both intervention groups and the 
control group. 
Mean age, years 
(standard deviation) 
Gender, n (%) 
 Male 

Marital status, n (%) 
 Single/living alone 
 Living together 
 Married 
 Divorced 
 Widowed 
Highest education, n 
(%) 
 Compulsory school 
 Apprenticeship 
 College 
 University 
Employment, n (%) 
 Full-time paid work 

 Student 
 unemployed 
 At-home parent 
 Retired 
Body Mass Index 
(standard deviation) 
Sleep medication within 
the last three months 
 Yes 

Current treatment for 
sleep problems 
(multiple answers 
possible) 
 General practitioner 
 Psychotherapy 
16 
(38.1%) 
26 
(61.9%) 







11 
(26.2%) 
9 (21.4%) 13 (31.7%) 
14 (34.1%) 
20 
(47.6%) 
2 (4.8%) 
0 (0.0%) 
5 (12.2%) 
0 (0.0%) 

2 (9.5%) 
12 (57.1%) 
0 (0.0%) 
11 
(26.2%) 
4 (9.5%) 
27 
(64.3%) 
2 (4.9%) 
12 (29.3%) 
3 (7.3%) 
24 (58.5%) 




24 
(57.1%) 
12 
(28.6%) 
5 (11.9%) 6 (14.6%) 
0 (0.0%) 
0 (0.0%) 
0 (0.0%) 
0 (0.0%) 
4 (9.8%) 
1 (2.4%) 
24.23 (5.20) 
23.60 
(3.64) 


2 (9.5%) 
0 (0.0%) 
0 (0.0%) 
1 (4.8%) 
23.62 (3.79) F(2,101) = 0.26; p = .78 
 
 
 
 

16 
(38.1%) 
26 
(61.9%) 




7 (16.7%) 7 (17.1%) 
0 (0.0%) 
2 (4.8%) 
1 (4.8%) 
0 (0.0%) 
??2(2) = 1.99; p = .37 
??2(2) = 3.01; p = .22 



 
 
 
M ANUS 
3 (14.3%) 
0 (0.0%) 
0 (0.0%) 
6 (28.6%) 
3 (14.3%) 
12 (57.1%) 
 
 
 


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 (4.8%) 
3 (7.3%) 
8 (19.0%) 4 (9.8%) 
16 
(38.1%) 
32 
(76.2%) 


0 (0.0%) 
2 (9.5%) 
6 (28.6%) 
??2(2) = 1.63; p = .44 
??2(2) = 1.89; p = .39 
??2(2) = 0.57; p = .75 



 
 
 
 

 Specialist 
 Medication 
 Other 

Chronicity of insomnia 
 3-12 months 
 More than 12 months 37 
5 (11.9%) 10 (24.4%) 
31 (75.6%) 
1 (4.8%) 
20 (95.2%) 
Preference 
 MCT 
 SRT 
 no preference 

20 
(47.6%) 
4 (9.5%) 
18 
(42.9%) 


1 (2.4%) 
22 (53.7%) 
1 (4.8%) 
14 (66.7%) 

Note. MCT = Multicomponent treatment; SRT = Sleep restriction treatment; CAU = Care as 
usual. 








 
 
 
 
 
 
 
 
 
 
Table 3 
Observed and estimated means for primary and secondary outcome measures, overall effects, within-group effects, and post-treatment between- 
group comparisons. 

Post 
(observed) 

ISI 
 MCT 


M 
(SD) 
16.20 
(3.75) 
17.37 
(3.44) 



8.88 
(4.94) 
11.29 
(4.99) 
17.43 
(3.83) 

14.75 
(4.73) 
Pairwise 
comparisons 
at post- 
treatment 
(Bonferroni- 
corrected) 
Between- 
group 
effect sizes 
at post- 
treatment 
(estimated 
means) 
Cohen’s d 
[95% CI] 
MCT vs. 
SRT: 
p = .159 
MCT vs. 
CAU: 
p < .001 
SRT vs. 
CAU: 
p = .049 
MCT vs. 
SRT: 
-0.46 
[-0.89; - 
0.01] 
MCT vs. 
CAU: 
-1.15 
[-1.70; - 
0.57] 
SRT vs. 
CAU: 
-0.68 
[-1.21; - 
0.13] 
MCT vs. 
SRT: 
-0.27 

PSQI 
 MCT 

10.12 
(3.13) 
11.05 41 

6.41 
(3.41) 
7.38 
MCT vs. 
SRT: 
p = .793 

Post 
(estimateda) 
FU 
(observed) 
FU 
(estimated b) 
Pre-post within- 
group effect sizes 
(estimated 
means) 






9.08 
(0.82) 
11.34 
(0.82) 


7.50 
(3.82) 
9.46 
(4.37) 


8.11 
(0.72) 
10.20 
(0.77) 


95% 
CI 
[1.11; 
2.11] 
[0.91; 
1.88] 

14.67 
(1.08) 


[0.01; 
1.25] 
Overall 
effects 
at post- 
treatment 
(group x 
time 
interaction)c 

F(2, 86.735) = 
6.56 
p = .002 


6.43 
(0.56) 
7.32 


5.44 
(2.26) 
7.04 


5.52 
(0.46) 
7.18 




[0.66; 
1.58] 
[0.71; 
F(2, 91.012) = 
6.63 
p = .002 







 

 


 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

ADS-K 
 MCT 


DBAS 
 MCT 


10.95 
(2.52) 

10.20 
(3.67) 
12.83 
(6.33) 
13.05 
(5.42) 


7.29 
(5.26) 
8.79 
(5.49) 
13.67 
(6.69) 

11.90 
(8.00) 
MCT vs. 
CAU: 
p < .001 
SRT vs. 
CAU: 
p = .007 
MCT vs. 
SRT: 
p = .690 
MCT vs. 
CAU: 
p = .012 
SRT vs. 
CAU: 
p = .168 
[-0.70; 
0.16] 
MCT vs. 
CAU: 
-1.09 
[-1.63; - 
0.52] 
SRT vs. 
CAU: 
-0.88 
[-1.41; - 
0.32] 
MCT vs. 
SRT: 
-0.33 
[-0.76; 
0.11] 
MCT vs. 
CAU: 
-0.80 
[-1.33; - 
0.25] 
SRT vs. 
CAU: 
-0.51 
[-1.04; 
0.03] 
70.63 
(21.83) 

41.65 
(24.04) 
MCT vs. 
SRT: 
MCT vs. 
SRT: 







10.23 
(0.74) 


[-0.38; 
0.83] 


7.17 
(1.02) 
8.92 
(1.02) 


7.16 
(4.68) 
6.96 
(5.26) 


6.73 
(0.88) 
7.48 
(0.94) 


[0.51; 
1.42] 
[0.30; 
1.20] 

12.21 
(1.36) 


[-0.41; 
0.80] 
F(2, 87.488) = 
3.32 
p = .041 

43.03 
(4.19) 






[0.72; 
1.66] 
F(2, 87.896) = 
15.19 



M ANUS 


 
 

 
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 


80.63 
(21.40) 

57.97 
(23.94) 
84.05 
(30.48) 

87.00 
(29.70) 
p = .045 
MCT vs. 
CAU: 
p < .001 
SRT vs. 
CAU: 
p < .001 
QoL 
VAS 
 MCT 


74.27 
(17.62) 
73.00 
(15.25) 


82.82 
(12.12) 
78.91 
(14.55) 
73.62 
(14.38) 

72.30 
(12.03) 
MCT vs. 
SRT: 
p = .836 
MCT vs. 
CAU: p = 
.020 
SRT vs. 
CAU: p = 
.207 
-0.61 
[-1.05; - 
0.16] 
MCT vs. 
CAU: 
-1.73 
[-2.31; - 
1.10] 
SRT vs. 
CAU: 
-1.17 
[-1.72; - 
0.59] 
MCT vs. 
SRT: 
0.26 
[-0.18; 
0.69] 
MCT vs. 
CAU: 0.85 
[0.29; 1.38] 
SRT vs. 
CAU: 
0.49 
[-0.05; 
1.02] 
Note. MCT = Multicomponent treatment; SRT = Sleep restriction treatment; CAU = Care as usual; ISI = Insomnia severity index; PSQI = 
Pittsburgh Sleep Quality Index; DBAS = Dysfunctional Beliefs and Attitudes about Sleep Scale; ADS-K = Center for Epidemiological Studies- 
Depression – German short version; QoL VAS = Quality of Life - visual analogue scale. a Based on models including all conditions and pre and 







[0.54; 
1.46] 



57.71 
(4.19) 

88.06 
(5.60) 


[-0.74; 
0.47] 


82.49 
(2.24) 
79.04 
(2.24) 


79.74 
(15.90) 
77.69 
(13.56) 

79.85 
(2.70) 
76.38 
(2.90) 
 



[-0.98; 
-0.10] 
[-0.84; 
0.04] 

72.25 
(2.93) 


[-0.50; 
0.71] 
F(2, 90.306) = 
2.10 
p = .128 



M ANUS 

 
 


 
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
post-assessments; b based on models including the two active conditions and baseline, post and FU-assessments. c Intention-to-treat (ITT) analyses; d 
DBAS was not assessed at follow-up. 









 
 
 
 


Morning protocol 
 Sleep efficacy (%) 
 MCT 
 SRT 
 Tiredness when 
going to bed 
 MCT 
 SRT 
 Sleep quality 
 MCT 
 SRT 
 Feeling 
unrecovered 
 MCT 
 SRT 
Evening protocol 
 Daytime tiredness 
 MCT 
 SRT 
 Concentration 
 MCT 
 SRT 

40 
39 
40 
39 
40 
39 
40 
39 
39 
39 
39 
39 
Pre-post within- 
group 
effect sizes 
(estimated 
means; 
pooled SD) 
Cohen’s d 
Between-group 
effect sizes 
(within-group 
ESMCT – within- 
group ESSR) 









Start of the 
intervention 
(estimated) 
After eight 
weeks 
(estimated) 
Pooled standard 
deviation over 
56 days 
Overall effect 
(group x time 
interaction)c 




79.43 (1.89) 
74.09 (1.90) 
84.91 (2.18) 
81.81 (2.26) 
F(1,2823) = 0.71 
p = .40 
13.96 
16.76 
4.03 (0.08) 
3.82 (0.08) 
4.02 (0.09) 
4.24 (0.09) 
F(1,2830) = 9.08 
p = .003 
2.80 (0.07) 
2.83 (0.07) 
2.43 (0.10) 
2.48 (0.10) 
F(1,2834) = 0.03 
p = .86 
3.02 (0.08) 
3.04 (0.08) 
2.63 (0.10) 
2.72 (0.10) 
F(1,2834) = 0.20 
p = .65 
3.99 (0.18) 
4.01 (0.18) 
3.48 (0.24) 
4.15 (0.24) 
F(1,2537) = 2.61 
p = .11 
4.59 (0.16) 
4.56 (0.15) 
5.48 (0.21) 
5.11 (0.21) 
F(1,2537) = 0.91 
p = .34 
0.84 
0.86 
1.04 
0.96 
0.96 
0.94 
1.85 
1.87 
1.72 
1.61 
-0.42 
-0.46 
0.01 
-0.50 
0.36 
0.36 
0.41 
0.34 
0.28 
-0.07 
-0.52 
-0.34 





 
 
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Mood 
 MCT 
 SRT 
 Relaxation 
 MCT 
 SRT 
Note. MCT = Multicomponent treatment; SRT = Sleep restriction treatment; a Number of participants with a least one value. Time was coded over 
F(1,2537) = 1.05 
p = .30 
F(1,2537) < 0.01 
p = .98 
3.39 (0.15) 
3.44 (0.15) 
5.31 (0.16) 
5.24 (0.16) 
3.05 (0.18) 
3.09 (0.18) 
5.73 (0.23) 
5.34 (0.23) 
-0.27 
-0.06 
1.53 
1.54 
1.56 
1.40 
0.22 
0.25 
39 
39 
39 
39 



 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 









 
 

Figure 1. Flow chart (MCT = Multicomponent treatment; SRT = Sleep restriction treatment; 
CAU = Care as usual) 







 
 



• 
• An abridged iCBT-I focusing on sleep restriction is effective in insomnia 
• The treatment gains remained stable up to 6-month follow-up 
• The effects of the two versions of iCBT-I did not differ from each other 
• Patients were more satisfied with the full version of iCBT-I 







 
 
